Articles | Volume 7, issue 6
https://doi.org/10.5194/jbji-7-249-2022
https://doi.org/10.5194/jbji-7-249-2022
Review
 | 
23 Nov 2022
Review |  | 23 Nov 2022

Early switch to oral antibiotic therapy for the treatment of patients with bacterial native vertebral osteomyelitis: a quaternary center experience, systematic review, and meta-analysis

Matteo Passerini, Julian Maamari, Tarek Nayfeh, Leslie C. Hassett, Aaron J. Tande, Mohammad H. Murad, Zelalem Temesgen, and Elie F. Berbari

Viewed

Total article views: 1,245 (including HTML, PDF, and XML)
HTML PDF XML Total Supplement BibTeX EndNote
942 255 48 1,245 80 41 34
  • HTML: 942
  • PDF: 255
  • XML: 48
  • Total: 1,245
  • Supplement: 80
  • BibTeX: 41
  • EndNote: 34
Views and downloads (calculated since 23 Nov 2022)
Cumulative views and downloads (calculated since 23 Nov 2022)

Viewed (geographical distribution)

Total article views: 1,185 (including HTML, PDF, and XML) Thereof 1,185 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 

Cited

Latest update: 13 Dec 2024
Download
Short summary
Despite a growing interest in oral therapy for native vertebral osteomyelitis, there is no evidence to recommend oral or parenteral therapy. From our single-center experience combined with a systematic review and a meta-analysis of the available literature, there is insufficient evidence to conclude that there is a difference in proportion of failure and relapse between an early switch to oral antibiotics and prolonged parenteral therapy. Further studies are needed to increase the evidence.